If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Zepbound ® (tirzepatide) injection
2.5 mg/ 5 mg/ 7.5 mg/ 10 mg/ 12.5 mg/ 15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How do I get Zepbound® (tirzepatide) vials?
Zepbound 2.5, 5, 7.5, and 10 mg vials are available exclusively through LillyDirect's self-pay pharmacy channel for patients with a prescription from their healthcare provider.
See important safety information, including boxed warning, in the attached prescribing information.
Zepbound Vial Availability
Eli Lilly and Company has created a self-pay pharmacy component of LillyDirect® where patients with a valid, on-label, electronic prescription from the health care provider of their choice can purchase Zepbound 2.5, 5, 7.5, and 10 mg vials.1,2
Zepbound 2.5, 5, 7.5, 10 mg vials are available.
As of February 25, 2025, the Zepbound 2.5, 5, 7.5, and 10 mg vials are available via LillyDirect's self-pay pharmacy channel.2
Lilly will continue to assess market conditions in determining optimal presentations and strengths to ensure appropriate patients can affordably access this Lilly medicine.3
Zepbound Vials List Price at LillyDirect
Distributing the vials via LillyDirect’s self-pay pharmacy channel offers transparent pricing for the Zepbound single-dose vials, cutting out extra costs to pass savings directly to patients. This option helps adults with obesity access the medicine they need, including those
- not eligible for the Zepbound savings card program
- without employer coverage, and
- who need to self-pay outside of insurance.1
Distributing the vials via LillyDirect ensures patients and providers can trust they are receiving genuine Lilly medicine.1
For information about the cost or price of Zepbound, please visit https://www.lillypricinginfo.com/zepbound for English or https://www.lillypricinginfo.com/es/zepbound for Spanish.
To learn more about LillyDirect, please visit: https://lillydirect.lilly.com.1
Enclosed Prescribing Information
References
1Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity. Press release. Eli Lilly and Company; August 27, 2024. Accessed February 25, 2025. https://investor.lilly.com/news-releases/news-release-details/lilly-releases-zepboundr-tirzepatide-single-dose-vials-expanding
2Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients. Press release. Eli Lilly and Company; February 25, 2025. Accessed February 25, 2025. https://investor.lilly.com/news-releases/news-release-details/lilly-launches-additional-zepbound-vial-doses-and-offers-new
3Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Date of Last Review: February 25, 2025